DJIA 17,164.95 -251.90 -1.45%
NASDAQ 4,635.24 -48.17 -1.03%
S&P 500 1,994.99 -26.26 -1.30%
market minute promo

Nektar Therapeutics (NASDAQ: NKTR)

company name or ticker

Nektar Therapeutics (NKTR) in Focus: Stock Rises 10.77% - Tale of the Tape

A Nektar Victory

This Week in Biotech: Actions Speak Louder Than Words

Regulatory actions provided the impetus to big moves for these five biotech stocks.

Relief for Nektar after AADPAC Voting - Analyst Blog

Why Nektar Therapeutics Shares Soared

Nektar shares soar after receiving a favorable vote from an FDA advisory panel. Find out what this vote means for Nektar's shareholders.

3 Stocks Driving The Drugs Industry Higher

Today's Top Biotech Stocks to Watch: Achillion Pharmaceuticals, Nektar Therapeutics and Progenics Ph

Today's top stories in health care and biotech.

Progenics, Nektar Still Halted; FDA Advisory Committee Expected To Conclude Thursday

Top Healthcare Movers For June 9, 2014

Small Phamaceuticals Rallying Following FDA Report

See More Articles...